Weiying Gu

机构：Soochow University, The First People's Hospital of Changzhou, Changzhou No.2 People's Hospital, First Affiliated Hospital of Soochow University, Changzhou Third People's Hospital, Nanjing Medical University · ORCID：0000-0003-4913-1610

发表论文 106 篇 · 总被引 695 次 · h-index 14

代表论文

• Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial (2025 · The Lancet Haematology · 被引 22)
• Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐ BCMA CAR T‐cell‐based therapy (2024 · American Journal of Hematology · 被引 22)
• A Machine Learning Model for Predicting Diabetic Nephropathy Based on TG/Cys-C Ratio and Five Clinical Indicators (2025 · Diabetes Metabolic Syndrome and Obesity · 被引 6)
• The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy (2025 · Frontiers in Immunology · 被引 4)
• High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study (2024 · Blood · 被引 4)
• Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma‐Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Multicenter Cohort Study of Jiangsu Cooperative Lymphoma Group (2025 · American Journal of Hematology · 被引 3)